Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era

Accuracy of Established Prognostic Staging Systems for Cardiac Transthyretin Amyloidosis in the Tafamidis Era

Background: Biomarker-based prognostic staging systems, including the National Amyloidosis Centre (NAC) and the Mayo staging systems, are widely-used but have only been validated for treatment-naive patients with cardiac transthyretin amyloidosis (ATTR-CA). Objectives: The purpose of this study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Maximilian Leo Müller, MD, Sebastian Spethmann, MD, Daniel Messroghli, MD, Anna Brand, MD, Isabel Mattig, MD, Katrin Hahn, MD, Ulf Landmesser, MD, Bettina Heidecker, MD
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:JACC: Advances
Subjects:
ATTR-CA
disease-modifying treatment
estimated glomerular filtration rate (eGFR)
high-sensitivity cardiac troponin T (hs-cTnT)
N-terminal pro B-type natriuretic peptide (NT-proBNP)
risk-stratification
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X24008494
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items